In this context, the reduced bioavailability of PP13 in blood group AB women in the first trimester may hypothetically contribute to the early pathophysiologic events at the maternal-fetal interfaces and increase the risk of preeclampsia in these women. Here, LGALS13 is linked to preeclampsia.